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Abstract 
Objectives: To investigate the use of lactobacillus as a simple tool for the diagnosis of 
bacterial vaginosis (BV) using wet mounts in pregnant women and to assess the 
positive predictive value of absence of lactobacillus for Human Immunodeficiency 
Virus Type-1 (HIV-1) infection. 
Methods: 409 pregnant women were enrolled from three randomly selected clinics 
around Harare. The women underwent clinical examination during which a speculum-
aided high vaginal swab was obtained and tested for BV using Amsel criteria, Nugent 
criteria and the simple lactobacillus method. 
Results: The prevalence of BV was 29% by Amsel criteria, 34% by Nugent criteria 
and 49% by the simple lactobacillus method. The sensitivity and specificity of the 
simple method using Amsel as the gold standard is 83% and 65% respectively with a 
kappa value of 0.40. The sensitivity and specificity of the simple test using Nugent as 
the gold standard is 86% and 82% respectively with a kappa value of 0.68. 
Sensitivities and specificities of individual Amsel criteria including lactobacillus for 
determining bacterial vaginosis with Amsel as the gold standard were as follows; 
discharge 15% and 99%, whiff 96% and 85%, clue cells 96% and 75%, pH 99% and 
22% and lactobacillus 83% and 65%. Using Nugent as the gold standard the 
respective sensitivities and specificities were as follows; discharge 08% and 99%, 
whiff 70% and 87%, clue cells 67% and 73%, pH 92% 22% and lactobacilli 86% and 
82%. The HIV-1 prevalence in the BV study sample (n=392) was about 46%. 
According to Amsel criteria only 26% (OR= 0.78) of the HIV positive participants 
have BV while according to the lactobacilli method 59% (OR=2.14) of the HIV 
positive participants do not have lactobacillus as part of the normal flora of the lower 
female genital tract. Amsel BV positive predictive value for HIV is 42% while 
lactobacillus positive predictive value for HIV is 56%. 
Conclusion: The sensitivity of the lactobacillus method is as good as Nugent criteria 
using Amsel as the gold standard. It is much simpler to perform, less expensive, easy 
to train and takes much shorter time to perform and therefore has a potential for a 
much wider use than both Amsel and Nugent criteria. The simple lactobacillus 
method has a better PPV for HIV-1 compared to both Amsel and Nugent. Amsel 
criteria can be improved by removal of subjective criteria.  
Key Words: Lactobacilli, bacterial vaginosis, aerobic vaginitis, Amsel criteria, Nugent 
criteria, diagnosis, sensitivity, specificity and predictive values.
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Chapter I 
1. Introduction and Background  
1.1 Diagnostic Microbiology 
The human body can be described by the types of bacteria which are normally found 
on or in the different parts of the body. For example the mouth, which is at the 
beginning of the alimentary canal, has a set of bacteria which is quite different from 
that found at the other end. There is a variation of bacteria along the length of the 
alimentary canal. The upper respiratory tract has its own type of bacteria while the 
lower respiratory tract is supposed to be sterile. The skin, which is the boundary 
between the inner tissues and the environment, has a typical bacterial population that 
colonises it. Some of these bacteria play very important homeostatic roles such that 
their absence may lead to abnormal conditions. Lactobacilli have for a long time been 
known to be the predominant bacterial flora of the lower female genital tract [1]. They 
produce lactic acid and hydrogen peroxide which help to keep other bacteria under 
control [2]. The presence or absence of lactobacilli can therefore be a useful indicator 
for normal or abnormal conditions in the lower female genital tract. Knowledge of 
this bacterial distribution, coupled with knowledge of the morphology, pathogenic 
characteristics, nutritional needs of the bacteria and certain host characteristics form 
the basis of most microbiological diagnostics. The terms exposure, colonisation, 
infection and disease are often used to describe the host-microbe relationship and 
must not be used interchangeably [3].
1.2 Bacterial flora of the lower female genital tract   
The female genital tract is divided into two major anatomic regions, the lower female 
genital tract (LFGT) and the upper genital tract which is normally sterile. The LFGT 
has an indigenous bacterial flora which can conveniently be divided into two groups, 
commensal and pathogenic.  
The main commensal bacteria are the lactobacilli which are found in concentrations of 
105 to 106 colony-forming units per gram of vaginal fluid while the other commensal 
bacteria occur in concentrations below 105 colony-forming units per gram of vaginal 
fluid and they account for 10% of the bacterial species recovered from a healthy 
vagina [4]. These bacteria include Bacillus spp, Corynebacteria spp, Diphtheroides 
and nondescript Streptococci [5]. In a normal healthy vagina, because of their 
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relatively bigger size, the area occupied by lactobacillus is far much greater than that 
covered by the other bacterial species.  
The pathogenic bacteria found in the lower female genital tract include facultative 
aerobes such as Staphylococcus spp, Streptococcus spp and Gardnerella vaginalis, 
Escherichia coli and anaerobes including Bacteroides spp, Prevotella spp, 
Peptostreptococcus spp, Mycoplasma hominis and Ureaplasma urealyticum [4, 6]. It 
is interesting to note that Mobiluncus spp, an important bacteria implicated in extreme 
cases of bacterial vaginosis does not appear neither as a commensal nor pathogen. 
Perhaps the advent of the Human Immunodeficiency Virus will create more pathogens 
in the female LFGT. 
1.3 Definition of Bacterial Vaginosis 
Bacterial Vaginosis (BV) is a disorder of the vaginal microbial ecosystem 
characterised by a shift in the vaginal flora, from the normally predominant 
Lactobacillus spp to one dominated by a mixed flora including Gardnerella vaginalis, 
Prevotella spp, Porphyromonas spp, Bacteroides spp, Mobiluncus spp and  genital 
Mycoplasma spp.[7]. This is a limited definition of BV because it does not mention 
the physiological and biochemical changes that characterise the condition. In view of 
this, BV can therefore be more comprehensively defined as an alteration in the normal 
vaginal microbial ecosystem and is characterized by three important features : (a) 
decreasing numbers of lactobacillus species which produce lactic acid and hydrogen 
peroxide which in turn inhibits the growth of some pathogenic bacteria, (b) an 
increase in the concentration of Gardnerella vaginalis, curved mobiluncus spp, 
peptostreptococcus spp, Mycoplasma hominis and anaerobic gram-negative rods 
belonging to the genera prevotella, porphyromonas and bacteroides which produce 
amines responsible for the fishy odour and (c) a pH greater than 4.5 resulting in the 
loss of the normal protective acidity of the vagina and subsequent alteration of the 
normal physiology of the vagina leading to a change in the quality and quantity of the 
discharge. Between these two definitions there are many variations of the definition of 
BV but it is important to note that in any definition of BV emphasis is placed on the 
gradual displacement of hydrogen peroxide-producing lactobacillus species by a 
variety of other micro organisms, amongst them Gardnerella vaginalis. These two 
organisms are the key players in the making of BV but unfortunately none of them are 
involved in the diagnosis of BV using Amsel criteria. Although it is a polymicrobial 
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phenomena one can never have BV without Gardnerella vaginalis and with many 
Lactobacilli! It is therefore quite logical to exploit this knowledge and develop a 
simple method that can be used for the diagnosis of BV. 
1.4 History of Bacterial Vaginosis 
Prior to 1955 BV was recognised as a vaginitis whose aetiology was not attributable 
to a specific agent such as Trichomonas vaginalis, Candida albicans or atrophic 
vaginitis, hence the name non-specific vaginitis. Then in 1955 Gardner and Dukes 
isolated Haemophilus vaginalis, an organism which they believed was the causative 
agent for non-specific vaginitis and subsequently changed the name from non-specific 
vaginitis to Haemophilus vaginalis vaginitis [8]. However, all Haemophili spp belong 
to this genus because basically they require X, V or XV factors for their growth but it 
was later discovered that the newly named Haemophilus vaginalis does not require 
any of these factors for its growth. Thus the taxonomy of the organism changed from 
Haemophilus vaginalis to Corynebacterium vaginale. And so the name of the disease 
changed from Haemophilus vaginalis vaginitis to Corynebacterium vaginale vaginitis. 
That corynebacteria are traditionally gram positive while Corynebacterium vaginale is 
typically gram variable was the reason why the search for a proper name continued. 
Thus the name was finally changed to its present eponym Gardnerella vaginalis [9]. 
Consequently Corynebacterium vaginale vaginitis also changed to Gardnerella 
vaginalis vaginitis.  
Three important factors again pushed for a name change. Firstly the suffix –itis 
denotes an inflammation characterised by redness, swelling, pain and the migration of 
leukocytes to the site of infection. This does not happen in BV and that is perhaps 
why the majority of women are asymptomatic. Secondly, the pathogenicity of G. 
vaginalis as a sole causative agent of BV was questioned as it could also be recovered 
from about 50% of women without BV [10]. Thirdly, better culture techniques 
revealed that anaerobic gram-negative bacilli, gram-positive cocci and genital 
mycoplasma were also significant microbial components of Gardnerella vaginalis 
vaginitis [6]. Finally the term bacterial vaginosis was adopted at a symposium in 
1983. This term recognises that many anaerobic or facultative bacteria are present and 
that classical signs of inflammation are absent.  
A different type of abnormal vaginal flora, aerobic vaginitis, has been recently 
described [11]. This condition is due to an overgrowth of aerobic bacteria such as 
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Group B streptococci, E. coli, S. aureus and others as opposed to an overgrowth of 
anaerobic bacteria in bacterial vaginosis. The organisms involved in bacterial 
vaginosis and aerobic vaginitis are indigenous to the LFGT. In both conditions, the 
dominance of lactobacilli is reduced. Because aerobic vaginitis and bacterial vaginosis 
are both caused by bacteria one wonders whether the name bacterial vaginosis should 
be changed to a more specific term, anaerobic vaginosis.  
1.5 Signs and Symptoms of BV  
Most symptomatic women complain of discharge and an unpleasant fishy-smelling 
odour which is more noticeable after unprotected sex. The reason why the odour is 
more noticeable after unprotected sex is because the alkaline semen increases the 
volatilization of the amines in the same manner that 10% potassium hydroxide (KOH) 
produces a fishy odour in the whiff test. Odour and discharge are two of the four 
diagnostic tools used by Amsel in his clinical composite criteria for the diagnosis of 
BV [12]. But the biggest problem associated with BV is that it is asymptomatic and 
the discharge is not exclusive to BV unless when it is observed by an experienced 
clinician! In Zimbabwe Mbizvo et al reported a 30% BV prevalence and that more 
than 50% of these women did not know that they had BV [13]. The fact that most 
women are asymptomatic is one of the reasons why this study’s objective is to 
develop a simple inexpensive method for the diagnosis of BV not only in pregnant 
women but in women of child bearing age who are apparently healthy. 
1.6 Risk Factors for Acquiring BV 
In Zimbabwe van de Wijgert et al found a strong relationship between intravaginal 
practices and vaginal flora disturbances, in particular the absence of lactobacillus 
species [14]. Intravaginal practices in Zimbabwe range from finger-cleansing with 
water to insertion of traditional herbs. Hawes et al site recent douching and having a 
new sex partner as being associated with acquisition of BV [15]. Other risk factors for 
BV are level of education, ethnicity, smoking, Intra Uterine Device usage, low 
socioeconomic status, having a new sex partner, multiple sex partners, increasing 
parity and frequency of having sex [16]. Sex, however, was never ever intended for 
anything else except for the single purpose of reproduction. Every other animal except 
man instinctively observes this fundamental biological phenomenon. That man has 
sex for pleasure may be the basic cause all STIs that plague mankind all over the 
world. If sex was purely for reproductive purposes a woman could have sex only 
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during the fertile period of her menstrual cycle and never during pregnancy and 
lactation. This may lead to a reduction of the frequency of sex on the part of the 
woman and a subsequent reduction in the occurrence of STIs including BV which is 
believed not to be an exclusive STI but somehow caused by sex [17].  BV may be 
caused by any habit or practice that interferes with the natural ecology of the vagina 
and to a certain extent unprotected sex may interfere with the natural ecology of the 
vagina by lowering the vaginal pH. If the frequency of unprotected sex is high then it 
may mean that the vagina is alkaline for very long periods and this may favour the 
growth of the bacteria responsible for BV.  
There is also evidence of existence of Lactobacillus-specific lytic bacteriophages 
causing the initial microbial shift that characterises BV. In vitro studies have 
demonstrated that tobacco-associated chemicals, antibiotics and nonoxynol 9 can 
increase concentrations of these lytic bacteriophages and thereby lead to an increased 
killing of vaginal Lactobacilli [18]. Whatever the risk factor it is important that there 
be a simple and reproducible method for rapid and inexpensive diagnosis of BV 
especially in developing countries where the disease is overshadowed by other life-
threatening diseases. 
1.7 Medical Significance of BV 
In a healthy state, the vagina serves as a natural incubator by providing favourable 
conditions of temperature, moisture, pH and nutrients conducive to the growth of the 
normal commensal vaginal flora. The vagina serves as a conduit to and from the upper 
genital tract. As a passage to the sterile upper genital tract and peritoneal cavity the 
vagina and its indigenous flora play an extremely important role of preventing 
infections and complications which can conveniently be divided into two groups, 
gynaecologic and obstetric.  
1.7.1 Gynaecologic Complications 
BV is related to considerable and possibly preventable infectious morbidity in non-
pregnant women. The sequalae of BV now include infertility, endometritis, pelvic 
inflammatory disease, post-abortal sepsis, post-surgical abortion infections, post-
hysterectomy infection, increased risk of HIV and other STIs acquisition.[19, 20]. BV 
has been suggested as a potential co-factor in the pathogenesis and progression of 
cervical intraepithelial neoplasia [21] but recent studies have found no association 
between BV and cervical intraepithelial neoplasia [22]. Bacterial vaginosis is a 
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potential risk factor for HIV transmission because of the elevated vaginal pH and 
other biochemical factors thought to impair the host defence mechanisms [23]. As pH 
increases so does the survival of HIV and thus transmission may be favoured. In 
Zimbabwe women without lactobacillus had an increased incidence of STIs and were 
more likely to be HIV positive [13]. 
1.7.2 Obstetric Complications 
BV is a potentially preventable cause of common and costly adverse obstetric 
outcomes. Many studies from all over the world link BV directly to a number of 
obstetric complications. These include pregnancy loss, still births, gestational 
bleeding, preterm birth, preterm labour, premature rupture of membranes, amniotic 
fluid infection, postpartum endometritis and post caesarean wound infections [5, 24-
27]. Listeria monocytogenes, a gram positive rod, is also known to cause similar 
obstetric complications but the difference is that it gains access to the amniotic cavity 
and membranes through haematogenous spread in the presence of intact membranes 
[5] rather than by ascension through the vagina. 
1.8 BV in Zimbabwe: A Critical Review 
Whilst descriptive microbiology of vaginal flora was started by Doderlein in 1894 [1], 
in Zimbabwe Mason pioneered descriptive work on vaginal flora in 1989 when he 
described the vaginal flora of women admitted with signs of sepsis following normal 
delivery, caesarean section or abortion [28]. In that study 20% of women who 
developed sepsis after delivery had Gardnerella vaginalis as indicated by the presence 
of clue cells. Clue cells, and not BV, were again associated with the development of 
sepsis in women delivered by caesarean section. In the entire study no direct reference 
was made to bacterial vaginosis. Instead BV was loosely referred to as Gardnerella 
vaginalis infection and only clue cells were used for the diagnosis. Clue cells are only 
one of the four clinical criteria developed by Amsel.  The Amsel clinical composite 
criteria was validated in 1983 and this is the method that should have been used for 
the diagnosis of BV. In 1990 culture of G. vaginalis was combined with presence of 
clue cells for the diagnosis of BV [29]. 63% cultured positive for G. vaginalis and had 
clue cells while 28% cultured positive for G. vaginalis and had no clue cells. This 
shows clearly that growing G. vaginalis is a poor indicator for BV. The high 
prevalence is expected as this was a high risk population. 
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Between 1995 and 1996 studies investigating intrauterine deaths, stillbirths, 
intrauterine infections, chorioamniotic infections and neonatal septicaemia were 
carried out [30-32]. Both studies go all the way to identify the organisms causing the 
infections but no attempt was made to establish the microbial state of the birth canal 
of the mothers at some point before or after delivery. Whatever ascending infections 
that got through to the uterus must have definitely passed through the vagina or the 
infant must have picked them up during birthing. The vagina serves as a link between 
the lower genital tract and the sterile upper genital tract. That it is dominated by a 
specific bacterial population should enable us to develop a simple method that can 
easily and quickly detect the emergence of abnormal conditions. Such a method 
would make it very easy to advocate routine screening for BV in pregnant women. 
There is also need for prospective studies to investigate the effect of BV on the 
outcome of pregnancy in Zimbabwe more especially after the discovery of a new 
organism, Atopobium vaginae, which was recovered from a tuboovarian abscess[33] 
and is said to be present in the majority of women with BV[34].  
The above studies show either how much BV is overshadowed by the STIs that are 
secondary to BV infection or the lack of appreciation of the role played by BV in 
facilitating reproductive tract infections in women, including the deadly HIV virus.   
However, current researchers in Zimbabwe seem to have realised the importance of 
BV and its association with sexually transmitted diseases in particular HIV and its 
acquisition[13]. Zimbabwe is one of the countries with the highest prevalence and 
incidence of HIV in the whole world. The HIV prevalence in women with no signs of 
reproductive tract infections was found to be about 30%[13]. Recent studies also seem 
to indicate that the prevalence of BV in Zimbabwe is high. In a  multi-centred 
regional study Zimbabwe had the highest prevalence of BV of about 50%[13].  It is 
therefore not a coincidence that we have the highest BV prevalence and one of the 
highest HIV prevalence in the world. There must be something in common between 
these two.  
In the study on asymptomatic women where the BV prevalence was about 30% it was 
disturbing to notice that over 50% of these women did not know that there was 
something wrong with them [13]. This means that the majority of these women will 
not seek health care and will therefore continue to be at risk of acquiring and 
transmitting infections, including HIV-1, each time they have sex. If they become 
pregnant they are again at risk for the adverse pregnancy outcomes associated with 
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BV. This problem is compounded by clinicians who are reluctant to probe probably 
because of the volume of patients that they attend to every day. 
There has been no study on the role of BV on adverse pregnancy outcomes in 
Zimbabwe. A study on neonatal septicaemia in Harare in 1990 did not look for BV as 
a risk factor and yet those babies that developed septicaemia had a lower birth weight 
than the control group [32]. BV is not screened for during pregnancy and is not one of 
the reproductive tract infections that are looked for in the syndromic approach for the 
diagnosis and management of STIs. This illustrates how much this clinical syndrome 
is overshadowed by other genital infections such as syphilis and gonorrhoea in 
Zimbabwe. 
The fact that BV is asymptomatic and is associated with many adverse outcomes in 
sexually active women of reproductive age, including acquisition of HIV, calls for the 
need for simple screening methods for its diagnosis in developing countries. There is 
also need to educate Zimbabwean women in general about the physiology of their 
bodies with the main aim of improving their reproductive health health-seeking 
behaviour.  
1.9 Diagnostic Methods for BV 
Various methods are available for the diagnosis of BV. These include culture, wet and 
dry microscopy, biochemical tests (gas-liquid chromatography) for metabolic by-
products of vaginal bacteria, oligonucleotide probe-based hybridization for G. 
vaginalis, multiplex polymerase chain reaction for the identification of BV associated 
organisms [35], redox potential [36]and rapid or office tests. However the costs and 
complexity of some methods have restricted them for research purposes and not for 
routine diagnosis of BV. 
1.9.1. Culture.  
G. vaginalis culture is a very sensitive method with a very low specificity for the 
diagnosis of BV and the organism can be recovered from about 36% to 50% of 
women without clinical signs of BV [35]. In one of the studies in Zimbabwe 91% 
cultured positive for G. vaginalis and 63% had clue cells while 28% had no clue cells 
[29]. If pH, whiff test and discharge were tested or observed the 63% could further be 
reduced to 30-40% which is about the prevalence for BV in Zimbabwe. Thus culture 
leads to over diagnosis and should not be used for directing therapy or as a test of cure 
after treatment because many women who harbour G. vaginalis usually lack any 
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objective signs of BV. It appears therefore that vaginal cultures for G. vaginalis may 
not be of any use whatsoever in routine diagnosis of BV. However we must always 
remember that culture played a very important role in the history of BV[8] and may 
continue to be useful in the identification of new BV-associated organisms such as 
Atopobium vaginae[34] and in research settings. 
1.9.2 Wet microscopy. 
Wet microscopy provides the simplest, practical, inexpensive and yet objective means 
for the evaluation of the disturbances of vaginal flora in women. Several techniques 
are available but the most frequently used are discussed below.  
 Amsel’s criteria, the traditional and reference method for the diagnosis of BV require 
that any three of the following four criteria be present; homogenous discharge, pH 
>4.5, fishy odour and clue cells[12]. Lactobacillus species, the cornerstone in any 
definition of BV, are completely ignored in Amsel’s composite clinical criteria. The 
inherent difficulty with Amsel’s criteria is that with the exception of pH, the 
remainder of the criteria are either subjective (discharge and whiff) or potentially 
technically difficult (clue cells) to judge. Taking Nugent criteria as the gold standard 
for the diagnosis of BV, the sensitivity and specificity of Amsel’s criteria are 70% and 
94% respectively [37]. Amsel is a combination of clinical and laboratory observations 
and that is why it is sometimes referred to as clinical composite. Discharge and pH are 
observed clinically while clue cells and fishy odour are tested in the laboratory. 
Because in Zimbabwe clinicians are not trained to look under the microscope one 
needs at least a nurse and a technician to obtain results and this is not always possible 
at many health delivery centres in the country. The biggest advantage of this method 
is that the result can be obtained within ten minutes! If the swab is sent to the lab at 
the beginning of a gynaecological examination the result will be available by the time 
the examination is completed. The biggest disadvantage of this method is the need to 
have a clinician and a technician on site and that the slides do not make a permanent 
record but this appears to be overcome by the recently introduced rehydrated smear 
technique [38]. In this technique slides are allowed to dry in the air as if they are 
intended for gram staining. The following day a drop of normal saline is added to the 
smear on the slide and a cover slip placed over the smear and examined in the same 
manner as wet preparations. But work has not been done to establish how long slides 
can be kept before examination.  
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In his work on fresh vaginal smears Donders acknowledges the importance of 
lactobacillus in the diagnosis of abnormal vaginal flora and subsequently classified 
lactobacillary morphotypes into three grades i.e. I, II and III [39]. Grade I contains 
predominantly lactobacilli and represents the normal flora while grade III contains 
many other bacteria with lactobacilli absent. The complexity of this method lies in 
grade II which he further subdivided into two grades, IIa and IIb. Grade IIa still 
contains more but reduced numbers of lactobacilli with few small bacteria present 
while IIb consist of numerous other bacteria with few lactobacilli present. Thus grades 
IIa and IIb show a shift from lactobacilli predominance to the predominance of other 
bacteria. The two grades may depict what Nugent refers to as the intermediate stage.  
Schmidt also developed a similar diagnostic criteria in which he weighted small 
bacterial morphotypes and lactobacillary morphotypes on a 0-8 score scale[40]. A 
score of 0-1 was regarded as normal, 2-4 as intermediate grade I, 5-6 as intermediate 
grade II and 7-8 as normal. This method is exactly the same as Donder’s except that 
the Roman numbers in Donders have been replaced by Arabic numbers by Schmidt, 
as shown in the table 1 below. 
Table 1. Comparison of Donders and Schmidt criteria. 
 Donders  Schmidt   Interpretation      
 Grade I  0-1    Normal  
 Grade IIa  2-4 Intermediate grade I Intermediate 
 Grade IIb  5-6 Intermediate grade II Intermediate 
 Grade III  7-8     Positive for BV.  
 
However, the presence of many grades increases the time spent on the microscope and 
raises the level of expertise required to read the slides. Lack of this expertise would 
invariably lead to intra and inter reader variability. A modification of the grading 
system by introducing a cut-off point that determines whether one has normal flora or 
abnormal flora could make this method more sensitive and easy to use without much 
technical expertise. The determination of the cut-off point requires careful 
observations because if the cut-off is placed too low it will exclude some with the 
disease while if it is placed too high it will include some without the disease. 
However, there will always be grey zone areas around the cut-off point as some cases 
struggle to resolve. 
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1.9.3 Stained smears 
The point of departure for the history of BV is the great work by Doderlein where he 
demonstrated that the normal vaginal flora consists of long gram positive rods which 
were later named Doderlein’s bacteria in his honour [1]. These bacteria we now know 
today as lactobacilli. Then in 1965 Dunkelberg examined 300 gram stained vaginal 
smears for “clue cells and dense areas of small gram-negative rods” and reported that 
all women having clinical signs of BV had gram stain smears consistent with BV[41]. 
Spiegel recognised the importance of lactobacillus in the diagnosis of BV and 
subsequently modified Dunkelberg’s work in 1983 when his diagnosis was simply 
made using proportions of lactobacillus species, small gram-negative rods, curved 
gram-variable rods and clue cells[42]. Presence of clue cells indicates full blown BV 
where most if not all the lactobacillus have been replaced by BV-associated 
organisms. It is therefore possible to miss diagnosis altogether in those patients who 
do not have full blown BV. This probably led to the development of Nugent scoring 
criteria where bacterial vaginosis is put on a 10-point scale where 0-3 is regarded as 
normal (predominantly Lactobacillus), 4-6 intermediate (mixed flora) and 7-10 
bacterial vaginosis (no Lactobacillus)[43]. The method of arriving at the scores is 
shown in table 2 below.  
Table 2: Scoring chart for Nugent criteria 
  Average number of         score    
Grade  bacteria per field Gram positive Gram negative Mobiluncus sp  
4+            >30          0          4          2  
3+           6-30          1          3          2                                 
2+           1-5          2          2                          1 
1+           <1                        3          1          1     
0             0           4          4              0          
Gram positive rods are exclusively lactobacillus while small gram variable and negative bacteria are 
part of the anaerobic flora responsible for Bacterial Vaginosis. 
 
The final BV score is arrived at by adding the individual points of the three types of 
bacteria i.e.  Long gram positive rods, gram negative short rods and curved gram 
variable rods. For example complete absence of Lactobacillus is grade 0 and scores 4 
points while more than 30 gram negative bacilli is grade 4 and also scores 4 points. 
The Nugent score for this would be 4 + 4 = 8. Mobiluncus species score 1 or 2 points 
and if they are present the points are added to the 8. Clue cells have no significant role 
in Nugent criteria which emphasizes the concept of “intermediate” in the diagnosis of 
BV. These may not have achieved full BV status but the truth is they have shifted 
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from the normal. They may advance to BV or revert to normalcy but at time of 
examination it is safer to assume they have BV.  
There are difficulties inherent in the Nugent method. Firstly, the interpretation of 
these smears is subjective because there is always uneven distribution of material on a 
dry smear and readings may be obtained from different parts of the slide. The 
microscopic area examined by an oil immersion objective is very small relative to the 
area covered by the smear. Secondly, over decolourised smears make it difficult to 
discern the small gram- negative rods. Thirdly, slides are often processed in batches 
and this may increase the waiting time which most asymptomatic cases are not 
prepared to do. An added advantage, however, in gram stain-based methods is that the 
slide provides a permanent record which can be reviewed later. 
Because Papanicolaou (Pap) smears are performed routinely it would be of great 
value if they can be used to screen for BV as well. It has been reported that Pap 
smears have a sensitivity and specificity of  90% and 97% respectively[44]. However 
the greatest limitation of pap smears for the diagnosis of BV is that the pap smear 
sample is a cervical rather than a vaginal specimen. However, it would be quite 
interesting to note how Nugent criteria would perform when applied to pap smears.  
1.9.4 Gas Liquid Chromatography 
Gas Liquid Chromatography (GLC) is a measure of metabolic by-products, mainly 
organic acids, of anaerobic organisms. These organic acids are certainly not produced 
by Gardnerella vaginalis. This technique therefore clearly demonstrated the 
involvement of other bacteria in the making of BV. 
Succinic acid, a metabolic by-product of anaerobic bacteria, is present at higher 
concentrations among women with bacterial vaginosis[6]. On the other hand, lactic 
acid produced by lactobacilli, the predominant members of the vaginal flora, is 
present at high concentrations in women without BV and are colonised by lactobacilli. 
A succinate/lactate ratio of greater than 0.4, based on gas liquid chromatography 
(GLC) peaks, was correlated with a clinical diagnosis of BV[6]. This method however 
is not adaptable for developing countries because of its dependence on expensive and 
complicated equipment which requires highly trained technicians to operate. 
Another GLC-based application is ‘the electronic nose,’ which detects volatile organic 
substances in vaginal fluids[45]. The electronic nose diagnostic system is a fully 
automated system which uses a single swab placed in a sealed envelope. The swabs 
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are analysed directly without the need for complex extraction procedures. The sample 
headspace is passed over an array of sensors each of which is specific for different 
volatile organic compounds based upon size shape and functional group. No matter 
how fully automated, any GLC system is complex and expensive and therefore not the 
right technology for the diagnosis of BV especially in developing countries.  
1.9.5 Rapid tests 
Rapid tests are similar in principle to GLC but have the advantage of not using 
complicated and expensive equipment. They are based on the detection of metabolic 
by-products of the micro-organisms that are responsible for BV. 
FemExam is a two-card system which detects elevated pH on one spot and 
trymethylamine on another spot on the same card. A high vaginal swab is touched on 
both spots and the results are read after one minute. Positives are indicated by colour 
changes. 
Another method, BV Blue test, is a chromogenic diagnostic test for the detection of 
sialidase enzyme in vaginal fluid. BV Blue detects vaginal fluid sialidase activity at 
levels of ≥7.8 Units where a unit of sialidase activity is defined as the amount of 
enzyme required to liberate I nmol of substrate/ml/min at 37°C[46]. A high vaginal 
swab is placed in the BV blue testing vessel and incubated for 10 minutes at 37°C 
after which BV Blue developer solution is added and the colour change is read at 
once. A blue or green colour indicates elevated levels of sialidase and therefore a 
positive result while a yellow colour indicates a negative result. 
1.9.6 Polymerase chain reaction 
A multiplex polymerase chain (PCR) reaction-based diagnostic system has been used 
to differentiate between bacterial vaginosis due to anaerobic bacteria from any other 
vaginal disorders [47]. This system is multiplex in the sense that it is detecting many 
organisms that cause the same condition as opposed to true multiplex PCR systems 
which detect different conditions at the same time. However the system uses three 
different primer sets to amplify ribosomal Deoxyribonecleac acid from Mobiluncus 
sp, B fragilis group and G vaginalis from a high vaginal swab. Detection of the 
amplified products was done by electrophoresis on 1.8% agars gel. As in gas liquid 
chromatography systems, PCR is quite labour intensive and uses expensive and 
sophisticated equipment which also requires highly specialised personnel. There is 
absolutely no point in using such methods when simpler and less expensive methods 
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such as the wet mount based ones are available. Such methods are suitable for neither 
developing countries nor developed countries and should be used only for research 
purposes. The other way of making such methods applicable is to be able to detect 
them concurrently with the detection of other STIs such as Neisseria and Chlamydia, 
rather than set up a PCR system for BV only.  
1.9.7 Redox Potential 
The reduction-oxidation (redox) potential is a physical process that measures the flow 
of electrons from one terminal to another using a millivoltmeter. Oxygen is the source 
of the electrons. The redox potential was markedly reduced (up to 200mV) among 
patients with bacterial vaginosis, demonstrating an oxygen-deficient or anaerobic 
environment [36]. The redox potential was consistently in the positive range among 
normal individuals, demonstrating aerobic environment. In my opinion this method 
however is useful for academic purposes and must not be used for diagnostic 
purposes. 
Table 3 on the next page shows the major advances in the microscopical diagnosis of 
BV from 1894 to present. 
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Table 3: Icons in the history and microscopical diagnosis of BV 
Year   Investigator  Diagnostic criteria    
1894   Doderlein A  Lactobacilli as part of normal vaginal 
      flora (descriptive) 
1914   Curtis A H  Bacteroides sp, Mobiluncus sp and  
      anaerobic cocci as causes of  abnormal 
      discharge (descriptive) 
1921   Schroder R  Used gram stains to categorise vaginal 
      flora into normal, intermediate and  
      pathogenic. 
1950   Weaver JD  Confirmed the absence of lactobacilli BV 
1955   Gardner HL  Isolated Haemophilus vaginalis which 
   Dukes   they believed caused a new infection 
      which they called H. vaginalis vaginitis. 
      Also described the clinical features of the 
      syndrome. 
1965   Dunkelberg W E Used gram stains to identify clue cells 
      and dense areas of small gram-negative 
      bacilli. 
1977   Smith R F  Direct microscopy versus culture  
      methods for the identification of  
       H. vaginalis. 
1977   McCormack W M H. vaginalis was not exclusively 
      associated with abnormal vaginal  
      discharge. 
1978   Pheifer T A  Addition of 10% KOH to release TMA, 
      the amine responsible for the fishy odour. 
1980   Greenwood J R Name finally changed aponymously to 
      Gardnerella vaginalis 
1983   Spiegel C A  The Spiegel criteria. Gram-negative rods, 
      curved gram-variable rods  and fewer 
      than 5 lactobacilli per oil immersion 
      field. 
1983   Amsel R  Amsel criteria. Used clinical  features 
      described by Gardner for diagnostic  
      purposes in wet mounts. Discharge, pH, 
      amine  odour and clue cells. 
1991   Nugent R P  Nugent criteria. Scoring system for  
      lactobacilli, gram-negative rods and  
      mobiluncus species on gram stains. 
1999   Donders G G  Wet microscopy classification of  
      relative quantities of lactobacilli and other 
      morphotypes into grades I, IIa, IIb and III 
2000   Schmidt H  Morphotypes scoring (1-8) in wet mounts 
2002   Hay P E  Simplified grading of gram stained 
      smears. Introduced two grades, 0 and IV 
2004   Ferris M J  Atopobium vaginae, new organism  
      involved in BV. 
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1.10 Some Important Definitions 
These are definitions of terms which are often used to describe the performance of 
screening or diagnostic tests. The contingency four-cell table shown below (table 4) is 
the basis for calculations of sensitivities, specificities and predictive values.  
Table 4: Dummy contingency table for demonstrating calculations. 
      Disease status             
     Present  Absent  Total          
       Positive       A        B  A+B        
Test  
      Negative       C        D  C+D            
      Total     A+C      B+D    
 
1.10.1 Sensitivity 
The sensitivity of a method is the proportion (A) of people with a disease (A+C) that 
the method can correctly identify as having the disease.  
 Sensitivity =                   A  
                               A+C 
1.10.2 Specificity 
The specificity of a method is the proportion (D) of people without a disease (B+D) 
that the method can correctly identify as not having the disease.  
 Specificity    =                 D  
                           B+D 
1.10.3 Positive predictive value 
The positive predictive value (PPV) of a test is the proportion of people with a 
disease (true positives) out of all who actually test positive by that test. The 
difference between all those that test positive and true positives is called false 
positives (B). 
 PPV   =                  A  
                          A+B 
1.10.4 Negative Predictive value 
The negative predictive value (NPV) of a test is the proportion of people without a 
disease (true negatives) out of all who actually test negative by that test. The 
difference between all those that test negative and the true negatives is called false 
negatives (C). 
 NPV =                   D  
                 C+D 
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1.10.5 Validity 
The validity of a method is the degree to which it is capable of measuring what it is 
intended to measure. 
1.10.6 Reliability/repeatability/reproducibility 
The reliability of a method is its ability to give consistent results when applied several 
times under the same conditions.  
1.11 Country Profile 
Zimbabwe is a Southern African country bordered by Zambia to the North, South 
Africa to the South, Mozambique to the East and Botswana and Namibia to the West. 
It has a population of approximately 14 000 000 people. Approximately 3 000 000 
people live in Harare and Chitungwiza. It has eight provinces each of which is divided 
into districts. The districts are further divided into rural zones and each rural zone is 
further divided into villages. A rural health centre (RHC) is the smallest health 
delivery facility and is designed to service a rural community within a 10km radius 
and altogether there are 1500 RHCs in Zimbabwe. The RHC refer patients to a district 
hospital (DH). There are 57 districts and each district has a DH. Altogether there are 
57 DHs. Other districts may have mission hospitals too. The DH and the mission 
hospital refer patients to the provincial hospitals and there are altogether 8 provincial 
hospitals. Finally the provincial hospitals refer patients to tertiary hospitals and there 
are four tertiary hospitals in Zimbabwe. 
1.12 Rationale 
From the early studies of the characterisation of normal vaginal flora we pick out the 
importance of Doderlein’s bacteria which we now know today as lactobacillus [1]. 
These bacteria are pivotal in any definition of bacterial vaginosis [4, 7]. The 
importance of lactobacillus is taken into consideration in the gram stain-based 
methods for the detection of BV and hence their improved sensitivity and specificity 
over Amsel’s criteria [12, 35]. This very important organism is completely ignored in 
the four criteria (elevated pH, discharge, odour and clue cells) that are used by Amsel 
[12] to diagnose BV in wet preparations. We know that lactobacillus species are 
visible in wet preparations under the microscope at 400X magnification [48]. In this 
study we wish to exploit the advantages of the gram stain-based [42, 43] and wet 
preparation methods [12, 48] to come up with a method that is simple, rapid and yet 
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sensitive for the diagnosis of abnormal vaginal flora and/or BV. Such a method 
should be very useful for screening purposes in developing countries, especially 
Zimbabwe, which have a high prevalence of BV [49, 50]. The method should initially 
be used to screen women into two categories i.e. those with abnormal vaginal flora as 
indicated by the absence of lactobacillus and those with normal vaginal flora as 
indicated by the abundance of lactobacillus. Those women with abnormal vaginal 
flora, if pregnant, would be considered at high risk for the many adverse pregnancy 
outcomes associated with BV. Identification and subsequent treatment of BV in 
women may reduce STIs including HIV which has caused untold suffering to many 
families in Zimbabwe. 
The purpose of this study therefore is to develop a simple method with high 
sensitivity and specificity which can be used for the identification of women with 
abnormal vaginal flora or BV and without much technical expertise. This method will 
be used not only in Zimbabwe but in all developing countries. 
1.13 Objectives 
1.13.1 General Objective 
 
To develop a simple, rapid and versatile method with a high sensitivity and specificity 
for the detection of abnormal vaginal flora and/or BV for use at peripheral health 
delivery centres in Zimbabwe as well as other developing countries. 
1.13.2 Specific Objectives 
 
1. To investigate the use of lactobacillus as a simple tool for the diagnosis of bacterial 
vaginosis in pregnant women using fresh vaginal samples. 
  
2 To assess the impact of lactobacillus as a criterion on the sensitivity and specificity 
of Amsel diagnostic criteria. 
 
3. To compare the prevalence of HIV-1 between pregnant women who have 
lactobacillus and those who do not have lactobacillus, and between those who have 






2.1 Study design 
 
This is a cross-sectional laboratory-based study where fresh vaginal samples were 
collected from pregnant women for the assessment of lactobacillus as a diagnostic 
tool for BV in Zimbabwe. The BV status of the women was determined by Amsel’s 
criteria which is regarded as the gold standard for the diagnosis of BV [12]. Samples 
were collected from the pregnant women during the third trimester. The sensitivity of 
lactobacillus alone and in combination with pH, and clue cells was also compared 
with the gram stain-based Nugent’s criteria. The study was part of an ongoing study 
where the motor development of infants born to HIV positive mothers on Nevirapine 
is being investigated with infants born to HIV negative mothers as controls.   
2.2 Study area 
 
The study was conducted at three randomly selected clinics near Harare in Zimbabwe. 
The clinics are Epworth polyclinic in Epworth, St Mary’s polyclinic and Seke North 
clinic both in Chitungwiza. 
2.2.1 Epworth Clinic 
Epworth is a poor peri-urban settlement situated about 10Km due east of Harare. It is 
administrated by the Epworth Local Board. The population of Epworth is 
approximately 87 625 according to the 2002 census. Most of the people in Epworth 
work in Harare. Some of the people are self-employed. This settlement was 
established by a religious organisation in the early seventies as many people fled from 
their rural homes. Epworth polyclinic is the only health centre that has maternity 
facilities in Epworth. It handles about 3000 deliveries per year at an average of about 
250 per month. Complicated cases are referred to Harare Central Hospital.  
2.2.2 St Mary’s Clinic 
St Mary’s is a low income high density residential area in the town of Chitungwiza, 
which is situated about 20km south east of Harare. It is administered by Chitungwiza 
Town Council. The population of St Mary’s is approximately 84 587 according to the 
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2002 census. The clinic is the only health centre that handles deliveries. St Mary’s 
clinic handles about 1500 deliveries per year. Complicated cases are referred to 
Chitungwiza General Hospital.  
2.2.3 Seke North clinic 
Seke north shares the same catchments area with St Mary’s clinic. It is under the same 
Chitungwiza Town Council and also refers patients to Chitungwiza General Hospital.  
2.3 Study Population 
The study population is composed of pregnant women in their third trimester that had 
already been enrolled in the ongoing Nevirapine study. Age was not a restriction for 
enrolment as long as they were pregnant. The women were permanent residents of 
either Epworth or Chitungwiza and were registered to deliver at any of the three study 
clinics.  
2.3.1 Study unit 
The study unit for this study was the pregnant woman.  
2.4 Selection criteria 
As part of an ongoing main study, the BV study used participants which had been 
enrolled using inclusion and exclusion criteria which are listed below. 
2.4.1 Inclusion Criteria 
• pregnant (3rd trimester) and attending ANC clinic 
• living in either Epworth or Chitungwiza 
• known HIV-1 serological status 
• intending to deliver at either Epworth, St Mary’s or Seke North Polyclinics 
2.4.2 Exclusion Criteria 
• used any antibiotics in the last two weeks. 
• used vaginal creams in the last two weeks. 
• ever douched or practiced intravaginal techniques such as finger cleansing. 
• had sexual intercourse within the last 8hrs 
• had a history of previous pregnancy complications 
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2.5 Sample size calculation 
The minimum number of participants required for this study was calculated using the 
formula n = z2pq/d2 where; 
n = minimum number required.  
z = the level of statistical significance of the expected result, in this case 1.96 for 95% 
confidence interval. 
p = the prevalence of the disease or condition. In Zimbabwe the prevalence of BV is 
about 30% [13]. 
q = 1-p 
d = maximum allowable error which is normally put at 0.05. 
Therefore  n    =   (1.96)2x 0.3(1-0.3) 
           (0.5)2
         =     3.8416 x 0.21 
           0.0025 
         =    323 participants    
2.6 Sampling Method  
Three clinics were randomly selected from a total of seven clinics in and around 
Harare and Chitungwiza. Participants were enrolled sequentially from January 2003 to 
December 2003 if they met the inclusion criteria.  
2.7 Subjects 
409 participants were enrolled from the three clinics as follows, 135(33%) from 
Epworth, 141(34%) from Seke North and 133(33%) from St Mary’s clinic. Out of the 
409 participants 17(4.2%) were missing Amsel data and were therefore removed from 
the sample leaving 392 participants whose distribution in the clinics were as follows; 
Epworth 132(34%), Seke North 132(34%) and St Mary’s clinic128(32%). The 
participants were all enrolled during the third trimester. The range of the duration of 
their pregnancies was between 28 weeks and 40 weeks.  The participants had been 
pregnant (gravida) between 1 and 5 times while they had given live births (para) up to 
5 times. 
2 participants had their ages missing and were therefore excluded from all the age 
calculations. Thus only 390 participants were available for age calculations. 
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2.8 Data collection 
Three types of data were collected. These are demographic, laboratory and clinical 
data. 
2.8.1 Demographic data 
A questionnaire was developed to collect demographic data but responses to this 
questionnaire were extracted from the parent study questionnaire because we did not 
want to subject the participant to another interview as this would impact negatively on 
subsequent follow up visits of the parent study. This demographic data was used 
primarily to describe the sample population.  
2.8.2 Laboratory data 
Three sets of laboratory data were collected. The first set of data was for the diagnosis 
of BV using Amsel criteria and the second set was for the diagnosis of BV using 
Nugent criteria. The final set of data was for the new simple lactobacillus method.  
2.8.2.1 Amsel criteria  
A high vaginal swab was collected during the pelvic examination and it was used to 
perform the whiff test and microscopic examination of clue cells in the laboratory 
[12]. Amsel criteria need an independent assessment of four individual criteria and a 
positive Amsel test requires the presence of any three of the four criteria which are 
pH, whiff, discharge and clue cells.  
2.8.2.2 Nugent criteria 
Bacterial morphology was evaluated from a gram stained vaginal smear using the 
100X objective (oil immersion) of a compound light microscope. Three types of 
bacterial morphologies are used for this evaluation. They are thick gram positive rods 
indicative of lactobacilli species, short slender gram variable rods (Bacteroides, 
Prevotella or Gardnerella spp) and curved gram variable rods characteristic of 
Mobiluncus species. These bacteria are referred to as the Nugent bacteria in this 
document. A score of 0-10 was assigned in light of the relative proportions of the 
above mentioned bacterial groups. A score of 0-3 was normal while a score of 7-10 
was positive for BV and a score of 4-6 was considered to be intermediate [43]. 
2.8.2.3 The Simple Lactobacillus method. 
The presence or absence of lactobacilli was noted in fresh high vaginal samples using 
the 40X objective and 10X eye pieces of a compound light microscope. All women 
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with BV have few or no lactobacilli in the LFGT. The absence of lactobacilli can 
therefore be used to indicate the presence or absence of BV. 
2.8.2.4 Laboratory tests for Sexually Transmitted Infections. 
Trichomonas vaginalis was diagnosed by observing characteristic movements in a wet 
smear using a compound light microscope at a magnification of 400X. Yeast buds and 
pseudohyphae were also examined in a wet smear to which a drop of 10% KOH was 
added. Syphilis was screened first with RPR (rapid plasma reaginin) and the positive 
ones were confirmed with TPHA (Treponema Pallidum Haemaglutination Assay). 
Herpes Simplex Virus type 2 (HSV-2) was tested using an Immunoglobulin G (IgG) 
based enzyme linked immunosorbent assay (ELISA). Human Immunodeficiency 
Virus type 1 (HIV-1) was screened using a rapid test called Determine manufactured 
by Abbott diagnostics and confirmed by another rapid test, Capillus, manufactured by 
Cambridge Biotek. RPR, TPHA, HSV-2 ELISA and HIV-1 are all serological tests. 
2.8.3 Clinical data  
Vaginal discharge and pH are two of the four criteria required for the diagnosis of BV 
using Amsel’s criteria which is sometimes referred to as the clinical composite 
criteria. These were collected during a pelvic examination. 
2.8.3.1 Vaginal discharge   
Discharge was observed before and after inserting a non lubricated sterile speculum 
into the vagina. Discharge was reported as positive if it was thin, adherent, 
homogenous and milky whitish. Other types of discharges, if present, were also noted. 
2.8.3.2 Hydrogen ion potential (pH) 
 The lateral wall of the vagina nearer the cervix was touched with a gloved hand 
which had a spot for reading pH. The colour change was matched with a colour coded 
guide provided by the manufacturer. 
2.9 Sample collection and transport  
A sterile non-lubricated speculum was gently inserted into the vagina during a pelvic 
examination by a qualified clinician. Two sterile cotton-tipped swabs were labelled 
with the participant’s main study identification number and used to obtain two 
samples of vaginal fluid both from the posterior fornix. One drop of normal saline was 
put on one swab soon after collection to prevent the swab from drying in the heat. The 
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swab was recapped and all swabs to which normal saline was added were sent to the 
laboratory around 14:00hrs the same day. These swabs were used for the diagnosis of 
BV using Amsel criteria and the Simple Lactobacilli method. 
The second swab was used to prepare a vaginal smear on a microscope slide. The 
microscope slide was air-dried and stored in slide boxes. These slides were later sent 
to the laboratory at the end of the week for gram staining and subsequent diagnosis of 
BV using Nugent criteria. 
2.10 Sample preparation 
2.10.1 Wet preparations (Amsel Criteria and Lactobacillus method) 
Two drops of normal saline (approximately 200uL) were placed on either sides of a 
glass slide using a 3ml transfer pipette. The drops were placed about 1cm from the 
ends of the slide so that they must not flow into each other at any stage during the 
process.  
The swab was removed from its sheath and rehydrated with two drops of normal 
saline. The swab was mixed gently in a circular motion several times in the drop on 
the left side of the glass slide. After mixing the swab was lifted and rotated through 
180 degrees and again mixed gently in a circular motion several times in the drop on 
the right side of the glass slide. The rotation through 180 degrees was to ensure that 
both drops received similar amounts of vaginal substances. The used swab was put 
back in its sheath and kept until the examination was complete when it was discarded 
in a biohazard container. A cover slip was gently placed on the drop on the left side of 
the glass slide. This drop was called the saline preparation. A drop of 10% potassium 
hydroxide (KOH) was added to the drop on the right side of the glass slide and at once 
whiffed for the liberation of a fishy odour indicative of the presence of volatile amines 
such as trimethylamine. Another cover slip was also placed on this drop and it was 
referred to as the KOH preparation. The whiff result was recorded as either positive or 
negative and recorded on the Amsel record sheet before the slide was examined under 
the microscope. The saline preparation was then put under the microscope and viewed 
for the presence or absence of clue cells under the 40X objective. The reason for 
recording the whiff test before examining the slide for clue cells was to make the two 
results independent of each other although done by the same person.  
The same saline preparation was also examined for the presence or absence of 
lactobacillus species and T. vaginalis [39] using the 40X objective.  
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2.10.2 Dry smears (Nugent criteria) 
One of the two high vaginal swabs was used to prepare a dry vaginal smear by rolling 
it along the middle portion of the slide. The smear was air-dried and delivered to the 
laboratory for gram staining in slide boxes. 
The slides were processed in batches of eight to ten. They were put back to back in a 
staining trough and fixed in 100% methanol for two minutes. The slides were 
removed from the staining trough, air-dried and then placed on a staining rack with 
the smear side facing up and the entire slide flooded with crystal violet, the primary 
stain, for one minute. The slides were washed one by one in gentle running tap water. 
The slides were again placed face up on the staining rack and flooded with lugols 
gram iodine solution for another minute. They were washed one by one with gentle 
running tap water and decolourised by adding acetone drop by drop until all the blue 
colour (crystal violet) had run out. The slides were washed once more in tape water 
and counterstained with safranin for 30 seconds. They were rinsed for the last time 
and blotted with absorbent paper and left to completely dry in the air.  
The slides were examined using the immersion oil objective and scored for BV using 
Nugent criteria. The slide was first scanned to get an impression of what bacteria were 
present and then the numbers of the Nugent bacteria in five representative fields only 
were counted and then averaged in order to obtain points for each type of bacteria. For 
example between 6 and 30 lactobacilli gets 1 point while the same number of small 
gram variable rods get 3 points All the points were then added to obtain the BV score 
which can be negative (0-3), intermediate (4-6) and positive (7-10). The example 
given above would get a score of 4 and would therefore fall in the intermediate 
category. See section 1.9.3 (table 2) for detailed description of the scoring system. 
2.11 Internal control 
During staining, Escherichia coli and Staphylococcus epidermidis which are known 
gram-negative and gram-positive organisms respectively were included to control the 
procedure. The staining procedure was valid only when these organisms were their 
true gram reaction. 
All the slides were then examined by two technicians (M and G). Results were either 
discordant or concordant. Concordant results were taken to be the BV result for that 
participant. Discordant results were independently examined by a third technician (O).  
A similar result obtained by any two technicians became the final BV result. Slides 
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with three different results were called discrepant and thus not included in the final 
analysis, as slides with an intermediate result. 
2.12 Statistics 
Data was transcribed from the primary data collection sheets into an excel program. 
The excel data was later imported into Statistical Package for Social Scientists (SPSS) 
version 11.0 which was used to calculate frequencies and prevalence. Chi-square test 
was used to test association significance and odds ratios (OR) between HIV and BV 
groups. 95% confidence intervals on selected proportions, sensitivities, specificities 
and predictive values were calculated manually from SPSS-generated contingency 
tables. 
2.13 Ethics 
Both the Medical Research Council of Zimbabwe and the Norwegian Ethical 
Committee approved the study. Participants were issued with identity numbers to 
mask their true identity. These identity numbers were used on all specimens collected, 
including the high vaginal swab for this study. The consent forms bearing client’s 
names and addresses together with study records were locked away and only available 
to study personnel. The participants were informed that participation in the BV study 
was of their own free will and that they were free to exit the BV study at any time 
without either jeopardising their participation in the parent study or their treatment at 




Data for analyses were available for 390 participants whose ages ranged between 16 
and 40years with a mean age of 24.57 years and a standard deviation of 4.88 years. 
182(46%) of the BV study participants are HIV positive while 210 are HIV negative. 
The participants were stratified in 5-yr age groups and the prevalence of HIV-1 in the 
age groups is shown in fig 1 below. 
Figure 1. Frequency of the 390 participants in age groups (blue/light) and prevalence 
of HIV (purple/dark) in the same age groups. 
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45 (11.5%) participants were intermediate according to Nugent criteria. Three 
different Nugent results were obtained on 29 participants and therefore a common 
result could not be reached. All the 74 (19.1%) participants were excluded from all 
analyses involving Nugent criteria. Thus the total number of participants for Nugent 
analyses is 318 while for Amsel is 392. 
 
Amsel, Nugent and the Simple Lactobacilli Method. 
 
Table 5: Prevalence and 95% confidence interval of bacterial vaginosis by the three 
methods. 
 Method  Prevalence  95% Confidence Interval
 Amsel         29    25-33 
 Nugent        34    29-39   
 Simple Lactobacillus       49    44-53          
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 The prevalence of BV using the three different methods is given above in table 5 
above. According to Nugent 45 participants were in the intermediate category while 
30 participants were discrepant. Of the 45 Nugent intermediate participants16 were 
classified as BV positive and 29 BV negative by Amsel criteria while 25 were 
classified as BV positive and 20 BV negative by the SLM. The level of agreement in 
the intermediate group between the SLM and Amsel criteria is kappa 0.01.  
The sensitivity and specificity of the SLM compared to Amsel criteria as the gold 
standard is 83% (95% CI 79%-87%) and 65% (95% CI 60%-70%) respectively with a 
kappa index of 0.39. The positive predictive value (PPV) and negative predictive 
values (NPV) are about 49% (95% CI 44%-54%) and 91% (95% CI 88%-94%) 
respectively. Table 6 was used to calculate sensitivities, specificities and predictive 
values.  
 
Table 6: Cross tabulation between Amsel criteria and the Simple Lactobacilli method. 
          Amsel Criteria 
    Positive  Negative           Total 
 
  Positive   93     98    191 
SLM 
  Negative   19   182    201 
Total    112   280    392 
SLM, Simple Lactobacilli Method. 
 
The sensitivity and specificity of Nugent versus Amsel as the gold standard is 82% 
(CI 78%-86%) and 72% (CI 67%-77%) respectively with a kappa index of 0.46. The 
PPV and NPV are 53% (CI 48%-58%) and 91% (CI 88%-94%) respectively. The 
intermediate group and discrepant slides are excluded. Calculations based on table 7. 
 
Table 7: Cross tabulation table between Amsel criteria and Nugent criteria. 
      Amsel Criteria 
    Positive  Negative           Total 
 
  Positive   71     64    135 
Nugent Criteria 
  Negative   16   167    183 
Total      87   231    318 
 
The sensitivity and specificity of the Simple method against Nugent criteria as the 
gold standard is about 86% (CI 82%-90%) and 82% (CI 78%-86%) respectively while 
the PPV and NPV are 78% (CI 73%-83%) and 89% (CI 86%-92%).The level of 
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agreement is Kappa 0.68. Again the intermediate group and discrepant slides are 
excluded. Calculations based on table 8. 
Table 8: Cross tabulation table between Nugent criteria and the Simple Lactobacilli 
method. 
              Nugent criteria 
    Positive  Negative           Total 
 
  Positive   116     32    148 
SLM 
  Negative     19   151    170 
Total      135   183    318 
SLM, Simple Lactobacilli Method. 
 
 
Performance characteristics of individual criteria. 
The sensitivities, specificities and predictive values of lactobacilli and other individual 
Amsel criteria i.e. discharge, whiff test (amine test), clue cells and pH when compared 
with Nugent criteria are shown in table 9 below.  
 
Table 9: Performance characteristics of individual Amsel criteria and lactobacilli for 
the diagnosis of bacterial vaginosis using Nugent criteria as the reference method. 
    
Criterion Positive(%) Negative  Sens.         Spec.     PPV          NPV  
Discharge   13   (4)     295    08           99       85    58 
Whiff  118 (37)     199    70           87       80    80 
Clue cells 140 (44)     177    67           73       65    75 
pH  256 (81)       49    92           22       47    76 
Lactobacilli 148 (47)     169    86           82       78    89 
Sens, Sensitivity; Spec, Specificity; PPV, Positive predictive value; NPV, Negative predictive value. 
 
Any three of discharge, whiff, clue cells and pH ≥4.5 represent the conventional 
Amsel criteria. The prevalence of bacterial vaginosis using this method is 28.6%. 
When discharge is replaced by lactobacilli, the prevalence of BV is 39.8% while 
replacing whiff by lactobacilli the prevalence is 31.9%. A participant is positive for 
BV when any three out of the four criteria are positive, as in the original Amsel 
criteria. The sensitivities, specificities and predictive values of these three 
combinations with Nugent as the reference method are shown in table 10 below.   
Table 10: Performance characteristics of the three combinations using Nugent as the 
reference method. 
Criteria (any 3 out of 4 is positive) Sensitivity Specificity PPV  NPV 
 
Discharge, Whiff, Clue cells, pH         53         91    82    72 
Whiff, Clue cells, pH, lactobacilli         76         88    82    83 
Discharge, Clue cells, pH, lactobacilli        61         91    84    72 
PPV, Positive predictive value; NPV, Negative predictive value. 
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HIV, BV and Lactobacilli. 
 
182(46%) of the BV study participants are HIV positive while 210 are HIV negative. 
The HIV negative participants served as the comparison group. According to Amsel 
criteria only 47 (26%), 95% CI of 20-32, p-value = 0.313, Odds Ratio (OR) = 0.78 of 
the HIV positive participants have BV while according to the Simple Lactobacilli 
Method 107 (59%), 95% CI of 52-66, p-value < 0.0001 OR = 2.14 of the HIV positive 
participants do not have lactobacillus as part of the normal flora of the lower female 
genital tract.  
The figures for Nugent criteria exclude 74 participants, i.e. 45 intermediate and 29 
with discrepant results. Thus there were 145 participants who were HIV-1 positive 
and 173 participants who were HIV-1 negative, making a total of 318 participants. 76 
(52%), 95% CI of 44-60, p-value 0.001, OR 2.13 of the HIV-1 positive participants 
have BV. 
The positive predictive values of Amsel BV, Nugent BV, Simple Lactobacilli BV and 
HSV-2 are as shown in table 11. Absence of lactobacilli is indicative of disturbance of 
vaginal flora or bacterial vaginosis. 
 
Table 11: Proportions of Amsel BV, Nugent BV, Simple Method BV and HSV-2 in 
the HIV-1 positive and negative groups and their predictive values for HIV-1. 
 
              HIV-1 Status 
    Positive(%) Negative Total    PPV  
Amsel BV       47(26)     65    112    42  
Nugent BV       76(52)     59    135    44 
Simple Lactobacilli BV            107(59)     84    191    56  
HSV-2                            143(76)     75    218    66  
HIV-1, Human Immunodeficiency Virus Type 1; HSV-2, Herpes Simplex Virus Type 2; BV, Bacterial 
Vaginosis; PPV, Positive Predictive value; NPV, Negative Predictive value.  
 
 
HSV-2 results were available for 370 participants. 218 of the 370 participants were 
HSV-2 positive, therefore giving an HSV-2 prevalence of 59%. Of the 218 that were 
HSV-2 positive 63(29%) had BV (OR = 1.22) according to Amsel criteria while 
115(53%) had no lactobacilli (OR = 1.54) as part of their vaginal flora. 
The prevalence of BV according to age among the HIV positive participants and the 




Table 12: BV prevalence and HIV positive predictive values using different BV 
diagnostic methods. 
         HIV+          BV Lacto             BV Amsel         Nugent BV                              
Age group          Freq         Pos        PPV    Pos      PPV         Pos       PPV 
16-20yrs           32       22(69)      46  07(22)    25        17(66)    46 
21-25yrs           70       42(60)      61  21(30)     50        33(63)    62 
26-30yrs           57          29(51)      60  02(21)     44          17(30)    62 
31-35yrs           19       12(63)      63          06(32)     60        08(61)    66 
36-40yrs           04       02(50)      33          01(25)     25          01(61)    20 
Total          182     107(59)      75          47(26)           76(52)          
Pos, positive; PPV, Positive Predictive Value. NB. The prevalence and PPV for Nugent BV are 
calculated using different figures because of the exclusion of intermediate and discrepant slides. The 
number of HIV-1 positives in the respective age groups, starting with the 16-20 yr age group is 26, 52, 
51, 13 and 3. The total number of HIV-1 positives = 145. See how these compare with figures under 




Amsel, Nugent and the Simple Lactobacilli Method. 
Both the Amsel and Nugent criteria were used as reference methods for the evaluation 
of the Simple Lactobacillus Method (SLM) although Amsel is regarded as the “gold” 
standard [51]. Both methods were used because of the need to highlight the 
differences in performance of these methods when different sets of conditions apply. 
Since Amsel and Nugent are frequently used as reference methods we feel that these 
differences in performance under different conditions may affect the sensitivity, 
specificity and predictive values of methods under evaluation. 
In his original article Amsel defines a pH > 4.5 as one of the four criteria for the 
diagnosis of bacterial vaginosis [12]. This clearly excludes pH values that are equal to 
4.5. However, others have used pH values ≥ 4.5 [52] while others have used a pH ≥ 
4.7 [15, 53]. Some have ventured to use pH values ≥ 5.0 as a cut-off for Amsel criteria 
[54]. These variations in pH cut-off values have an effect on the overall performance 
of the test and also on the prevalence of the disease being investigated. When the 
sensitivity and specificity of a diagnostic method is altered it follows that the 
prevalence and incident measurements of the disease are altered and subsequently any 
methods evaluated against it are also affected. In this study when pH was changed by 
only 0.1 pH unit, from ≥ 4.5 to a pH > 4.5, the sensitivity, specificity and predictive 
values of the SLM changed from 83%, 65%, 49% and 91% to 86%, 61%, 38% and 
94% respectively. The prevalence of bacterial vaginosis as measured by Amsel 
changed from 28% to 21%. Depending on the type of disease and magnitude of the 
change this may cause public health officials to make inappropriate decisions which 
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may lead to regrettable consequences. It therefore appears that even these very 
objective criteria cited by Amsel can be made to perform subjectively, thereby further 
eroding the very basic properties of Amsel criteria that have established it as a 
reference method in the diagnosis of BV.  
Looking closely at table 6 in the result section we notice that the number of false 
positives (98) outnumber the true positives (93) by more than 100%. This tells us that 
our method is picking up not only BV but other conditions that are not picked up 
Amsel criteria. We know that absence of lactobacilli is not synonymous with BV but 
we also know that absence of lactobacilli is a positive indicator of vaginal flora 
disturbance. Aerobic vaginitis is one form of vaginal flora disturbance that is signalled 
by replacement of lactobacilli by aerobic organisms such as Group B streptococci, E. 
coli and S. aureus [11] and it may be possible that the SLM  is also picking up this 
condition. The false positives also include some of the participants with only one or 
two criteria and therefore fail to count as positives using Amsel criteria, i.e. any three 
out of four. The overall effect of the false positives outnumbering the true positives is 
to reduce the PPV of the SLM which in this case is barely 49%. This PPV is only for 
BV and not for vaginal flora disturbance.  
When the SLM is compared with the Nugent criteria the sensitivity, specificity, 
positive and negative predictive values are 86%, 82%, 78% and 89% respectively. 
The Kappa index is 0.68. The figures look better but this is because the intermediate 
group was not included in the analysis. The Nugent intermediate group is difficult to 
diagnose and is the source of many inter-reader variations [55]. Different scoring 
combinations in the intermediate group may lead to the same points. Since the slides 
are judged by the total points and not by the individual scores, this maybe the source 
of wide inter-reader variabilities in this group. At the extremes are slides with no 
organisms scoring the same 4 points as slides with more than 30 lactobacilli and more 
than 30 small gram negative rods! The source of this confusion is the inverse relation 
that there is between lactobacillus and BV. Table 13 shows different score 
combinations that gives 4 points.  
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Table 13: Different score combinations leading to the same score in the Nugent 
intermediate group. 
 Grade  Lactobacilli score Gram negative rods  Points  
               points     
 
 0 (no Organisms) 4       +  0        =         4 
 1+ (<1 per field) 3       +  1        =      4 
 2+ (2-5 per field) 2       +  2        =      4 
 3+ (6-30 per field) 1       +  3        =      4 
 4+ (>30 per field) 0         +  4        =      4  
 
 To explain the variability the SLM was evaluated against Amsel on the intermediate 
group and the sensitivities, specificities and predictive values were 56%, 45%, 36% 
and 65% respectively (table 14) with a Kappa index of 0.01.  
The intermediate group also includes the majority of cases that have only one or two 
positive Amsel criteria and therefore not enough to count as positives. Figure 2 below 
is an effort to try and describe the dynamic nature of BV status within a population 
regarding the intermediate group. We have participants who can move from normal 
directly to BV and vice versa (long arrows). For these the intermediate stage is only 
transient. We also have others that are moving back and forth between normal and 
intermediate and between full blown BV and intermediate (short arrows). When 
participants are intermediate it is difficult to tell which way the infection is heading, 
unless they are followed prospectively. We know that women may have recurrent BV 
but it is also important to establish whether there are chronic cases of BV and 
intermediate stages. 
In most intermediate cases the densities of the organisms on the slide are so 
conspicuously varied such that it is almost impossible to get the same score from 
repeated readings of the same slide. This variation in the densities of the organisms is 
also present in the negative and the positive slides but the variation does not affect the 
score because the counts per field far exceed the >30 organism which is the magic 




Fig 2: Relationship between normal, intermediate and full blown BV 
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The Nugent intermediate group is difficult to diagnose and may be the source of inter 
and intra-reader variations. This was confirmed by the poor sensitivities, specificities 
and predictive values calculated using Amsel as the reference method (Table 14). 
 
Table 14: Performance characteristics of the SLM on the intermediate category. 
     Amsel Criteria 
    Positive  Negative          Total 
 Positive    09     16   25 
SLM       
 Negative    07     13   20 
Total      16     29   45 
SLM, Simple Lactobacillus Method. 
 
These were 56%, 45%, 36% and 65% respectively with a Kappa index of 0.01. 
The intermediate group may either represent a completely different type of abnormal 
vaginal flora namely aerobic vaginitis [11] which both the Amsel and Nugent criteria 
are not able to adequately address. The 30(11.5%) slides which are intermediate and 
the other 45 (19%) slides that were discrepant perhaps could have been reduced had 
we standardised the microscopic image area because different microscopes have 
magnifications which may differ from each other and from the original microscope 
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used by Nugent by as much as 300%[55]. This means that microscopes have an effect 
on the sensitivity, specificity and predictive values of Nugent criteria.  
 
However the trend in BV diagnosis appears to be returning to the original diagnosis 
upon which Amsel evolved. Schmidt and Donders have explored various methods for 
the diagnosis of BV in wet mounts [39, 40, 48]. This seems to indicate that the 
solution to the diagnosis of bacterial vaginosis lies close to the definition of the 
condition, a shift in the micro ecology of the vagina.  Amsel provides an accurate 
clinical description of bacterial vaginosis and can be used for diagnostic purposes but 
because of the subjective criteria that may affect its reliability we suggest that it must 
not be used as a reference method. Whilst we acknowledge that bacterial vaginosis is 
not a monoaetiologic condition we would like to emphasize that certain organisms are 
key players in the aetiology of BV and these are lactobacilli and G. vaginalis. 
Lactobacilli are negatively associated with BV while G. vaginalis is positively 
associated. Therefore if one or both of these organisms are included in the diagnostic 
criteria it would certainly improve the diagnosis of bacterial vaginosis and hopefully 
improve reliability of the method.  
 
Performance characteristics of individual criteria 
Table 9 displays the individual performance of the four Amsel criteria and also that of 
lactobacilli and we observe that the sensitivity of lactobacilli comes second after pH, 
thus confirming why it should be included as one of the criterion for the diagnosis of 
bacterial vaginosis in wet preparations. Lactobacillus is an objective criterion and 
with minimum training it should provide results with minimum inter and intra-reader 
variability. However, the comparison in table 9 was made after removal of the 
intermediate group in order to make the Nugent result dichotomous. Even when it was 
compared with Amsel criteria (results not shown) the sensitivity of Lactobacilli was 
still second to pH, further confirming the need to include it as a criterion for the 
diagnosis of BV. Based on its individual performance we therefore replaced some of 
the Amsel criterion, one at a time, with lactobacilli and the two best combinations are 
shown in table 10, together with the conventional Amsel criteria in the first row. The 
combination with a higher bacterial vaginosis prevalence replaced discharge with 
lactobacillus while the other combination replaced the whiff test with lactobacilli. A 
participant was positive if at least any three positives out of four were as in the 
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original Amsel criteria. Both methods show a higher prevalence of bacterial vaginosis 
than Amsel criteria and this appears to indicate some level of misdiagnosis due to the 
subjective nature of some of the clinical criteria, [56] namely discharge and whiff.  
Any three of whiff, clue cells, pH and lactobacillus for the diagnosis of BV was then 
compared against Amsel (any 3 of discharge, whiff, pH and clue cells) and Nugent 
criteria and the results are shown in table 15 below. With a near 100% sensitivity 
against Amsel this method is done at exactly the same cost with Amsel but has an 
advantage of having more objective criteria which means that it is more reliable. 
Another important objective criterion which must be considered for use is a group of 
small bacteria that adhere to each other, forming clumps and floating between 
epithelial cells [40]. These bacteria, pH, lactobacillus and clue cells would provide an 
all subjective criteria for the diagnosis of bacterial vaginosis.  
Table 15: Combination of whiff, clue cells, pH and lactobacilli compared with Amsel 
and Nugent 
     Amsel n = 392          Nugent n = 318  
Sensitivity   0.99(95% CI = 98-100) 0.76(95% CI = 71-81) 
Specificity   0.84(95% CI = 80-88) 0.88(95% CI = 84-92) 
Positive Predictive Value  0.71    0.82 
Negative Predictive Value  1.00    0.83 
Kappa                0.71    0.64   
CI, Confidence Interval. 
 
HIV, BV and lactobacilli 
The simple lactobacilli method uses the presence or absence of lactobacilli as an 
indicator of abnormal vaginal flora and/or bacterial vaginosis. With a p-value far less 
than 0.0001 this study has demonstrated that the association between absence of 
lactobacilli and presence of HIV is highly significant. In 1999 the absence of 
lactobacilli in non pregnant asymptomatic women was associated with being positive 
for HIV (odds ratio 0.24)[13] while in this study the odds ratio on pregnant 
asymptomatic women is 2.14, an increase of almost ten times higher than the 1999 
figure.  A similar comparison between Amsel BV and HIV yields a p-value of 0.313, 
thus strangely indicating no association although several studies have reported an 
association [13, 14, 57]. Women without lactobacilli (odds ratio 2.14, p-value 
<0.0001) are more than twice likely to get HIV than women with bacterial vaginosis 
only (odds ratio 0.78, p-value 0.313). Absence of lactobacilli in the reproductive tract 
has a PPV of 56% for HIV infection. The relationship between HIV and BV among 
the age groups is shown in table 12 in the results section. If we look at the PPV of 
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Amsel, Nugent and the SLM for HIV we notice that Amsel has the least prediction for 
HIV across the age groups while Nugent and the SLM are both higher and 
comparable (fig 3). Both methods have over 60% PPV in the age groups between 21 
and 35yrs. However, the SLM has an advantage over Nugent because it is much 
simpler to perform and therefore has a potential for a much wider application.  
Fig 3. Comparison of Positive Predictive Values of Amsel, Nugent and the Simple 
Lactobacillus Method for HIV-1. 




















When confronted with a decimating disease like AIDS, whose treatment is currently 
not afforded by the majority of people in developing countries, it is much better and 
cheaper to identify individuals at risk and subject them to well structured preventive 
strategies which are intended to reduce transmission and increase knowledge. 
Although the disease burden is relatively small in the younger age groups it appears 
that they are the ones at a higher risk of acquiring infection.  
Table 16: Cross tabulation table of the 88 mothers in the 16-20yr age group showing 
their lactobacilli BV and HIV status. 
      HIV Pos HIV Neg Total 
 Lactobacilli BV Positive    22    26     48 
 Lactobacilli BV Negative          10    30     40 
 Total       32    56     88 
 BV, Bacterial vaginosis. 
 
There are 88 young mothers aged between 16 and 20yrs of which 32(36%) are HIV 
positive and 56 (64%) are HIV negative (Table 16). 22 (69%) of the HIV positive 
young mothers have no lactobacilli in the vagina while 26 (46%) of the HIV negative 
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young mothers also have no lactobacilli in the vagina. This means that these 26 young 
mothers are at a higher risk of acquiring HIV and must therefore be targeted for well 
structured preventive strategies. The aims of preventive strategies for these women 
must include restoration of the lactobacilli, couple counselling and condom use. It is 
also important to try and establish any behaviour, no matter how subtle, that may 
appear to be the cause of the reduction of lactobacilli. There are also 30 HIV negative 
women who still have lactobacilli in the vaginal ecosystem. These women have a 
relatively lower risk of acquiring HIV and the preventive strategies towards them 
must be different from those directed at those that have already lost their lactobacilli. 
Here the aim is to ensure that the vaginal ecosystem is maintained. When counselling 
the HIV negative women who still harbour lactobacilli it must be made quite clear 
that it is very possible to acquire HIV even with lactobacilli in the vaginal ecosystem. 
It is just the chance which is reduced but the possibility is there. This does not, 
however, imply that one has to lose lactobacilli first before acquiring HIV.  
If we look at the individual years within the 16-20yr age group we notice that 2 of 6 
(33%) are already infected at 16yrs while 10 of 24 (42%) are infected at 20yrs (table 
17). The risk of getting infected with the virus is increasing with age. It is really not 
the age that matters but it is the increased frequency of having unprotected sex. It 
therefore appears that this age group is responsible for fuelling the spread of HIV. It 
has been documented that higher HIV seroconversion (transmission) is associated 
Table 17: Distribution of HIV-1 infections within the 16-20 yr age group 
                         HIV-1 Status 
  Age (yrs) Number  Positive  Negative 
  16        6         2 (33)       4 
  17      14         3 (27)     11 
  18      19         9 (47)     10 
  19      25         8 (32)     17 
  20      24       10 (42)     14    
  Total      88       32 (36)     56  
 
with a younger maternal age [57].  In a monogamous heterosexual relationship HIV 
transmission depends not only on the woman’s behaviour but also on that of her 
partner(s) as well. We can also state that infection in the 16 year old mothers and 
perhaps in the whole age group is fairly recent because they have not been sexually 
active for a long time. They have relatively more sexually active years ahead of them 
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than the rest of the groups and must therefore be made prime targets for intervention 
programmes. 
As these young mothers graduate into the next age group they bring with them their 
HIV status and affect both the prevalence and incidence in that group. Because they 
are sexually active they automatically become involved in the transmission dynamics 
of the virus. The positive will transmit and the negatives become the victims. This 
transmission is not only limited to their current age group but occurs across the entire 
sexually active age groups including those that are outside the reproductive ages. This 
helps to elaborate what is meant by fuelling the epidemic. 
We would have wanted to show what is happening in the 31-40 year mothers but 
unfortunately the numbers are too few to make any meaningful conclusions. But we 
can speculate that very little transmission goes on in this age group but this is where 
the disease burden is quite evident. Those that are positive are probably graduating 
from the previous age groups and with death taking its toll they become fewer and 
fewer. The chances therefore of the negatives to seroconvert are relatively small 
unless something drastic happens to their behaviour and those of their partners.   
This information may be very useful in revising existing HIV counselling scripts and 
other preventive strategies. It is important to bring to the attention of the women that 
although they are not HIV positive, but because of the absence of lactobacilli in the 
lower genital tract, if they continue to have unprotected sex, their chances of acquiring 
HIV are very high. Knowledge about the HIV-lactobacilli association may help reveal 
hidden and unknown risk factors that can be used to reduce HIV transmission. This 
knowledge should be used to complement the existing knowledge about the 
relationship between HIV and BV rather than replace it. If BV screening is made 
available women should be able to visit a clinic and ask for their lactobacillus status to 
be checked. There should be a deliberate effort by health care-givers to talk about 
vaginal health at primary health clinics.  We need to deliberately target preventive 
strategies at women that are sexually active and are below the age of 20. In that age 
group we need to pay particular attention to women that do not have lactobacilli in the 
lower genital tract and those that have bacterial vaginosis. Eventually this may reduce 
transmission within this age group and indeed across all age groups.  
The idea of targeted preventive strategies appears to provide a convenient entry point 
for vaginal health education to complement the existing reproductive health education 
whose main emphasis is to avoid teen age pregnancies, unwanted pregnancies and 
 39
subsequent abortions. Specific aids-related health education programs may be useful 
in arresting the spread of HIV by bringing to the attention of vulnerable women both 
silent and salient issues that puts them at risk. There may be traditional limitations to 
vaginal health but faced with the AIDS scourge we are forced to explore convenient 
ways of communicating the messages. Capitalising on the already existing 
relationship between mother and daughter can be a good starting point.   
We observe that of the HIV positive women 59% do not have lactobacilli and 26% 
have bacterial vaginosis. Being pregnant is enough evidence that they are having 
unprotected sex. In a heterosexual relationship is the male partner at a higher risk of 
acquiring HIV by having sex with a woman who is HIV positive and is devoid of 
lactobacilli in the vagina or has bacterial vaginosis? Is there more viral shedding in 
the genital tract of HIV positive women devoid of lactobacilli?  
3.2 Study Limitations 
Our study participants were all enrolled in the third trimester of their pregnancy. This 
fact, coupled with the cross sectional nature of the study, in principle excludes the 
possibility of relating absence of lactobacilli to preterm effects on the BV study 
population. This study therefore failed to examine the effect of not having 
lactobacillus to early abortions, premature rupture of membranes and preterm births.  
Although BV is the same in pregnant women as in non-pregnant women we are 
sceptical about generalising our results to non-pregnant women since pregnant women 
may behave hygienically different from non-pregnant women. The different 
behaviour may make one group more susceptible to BV acquisition than the other. For 
example, pregnant women may be involved in vaginal cleaning before visiting the 
clinic and this may affect the bacterial population. The study should therefore have 
included, as controls, non-pregnant women whose visit to the clinic was neither for 
obstetric nor gynaecologic reasons. 
The study looked at only the presence or absence of lactobacilli. We did not count the 
number of lactobacilli per microscopic field and as a result we were not able to 
increase the sensitivity by including those with few lactobacilli per microscopic field 
as positives. We were also not able to establish cut-offs for the sensitivities.  
The relationship between HIV and Lactobacillus could have been better demonstrated 
if the study was prospective and the participants randomised to one group receiving 
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extensive counselling to reduce HIV transmission and the other no counselling.  HIV 
incidence would be evaluated after a given period in the two groups. 
The technician received training rather late during the study and this could mean that 
the diagnosis was more accurate in the last set of slides than the initial ones. The same 
microscope was used for wet mounts but unfortunately three different microscopes 
were used for the Nugent Criteria and this may result in assigning different Nugent 
scores [55]. The delay in sending swabs to the laboratory may have lead to an under 
estimation of the whiff test as the volatile amines could have long evaporated in the 
heat by the time the swabs are delivered to the laboratory. The validity of clue cells 
and whiff test could have been enhanced tremendously if two technicians had read the 
wet mounts simultaneously. 
3.3 Conclusion 
The sensitivity and specificity of the lactobacillus method is comparable with both the 
Amsel and Nugent. In addition it has a potential to identify most women with 
abnormal vaginal flora. There is a strong association between absence of lactobacilli 
and presence of HIV-1. The Simple Lactobacillus method has shown a better positive 
predictive value for HIV-1 compared with both Amsel and Nugent. Further, it 
appeared that replacing discharge and whiff with lactobacillus one at a time is likely 
to improve the sensitivity of Amsel criteria to identify the majority of pregnant 
women with bacterial vaginosis. 
  
3.4 Recommendations 
The simple lactobacillus method should be further standardised by establishing cut-off 
values that can accurately distinguish bacterial vaginosis from other conditions that 
result from the loss of lactobacillus, such as aerobic vaginitis.  
HIV negative women, especially those below the age of 30, without lactobacilli as 
part of the normal vaginal flora should be targeted for preventive strategies including 
extensive couple counselling to ensure reduced transmission. Furthermore, Ministries 
of Health, Education, Sports Youth and Culture and any other relevant ones should 
explore the best possible ways of introducing vaginal health education in the schools.  
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3.5 Future Study Topics 
 
Atopobium vaginae, a strict anaerobic, metronidazole resistant, gram-positive 
coccobacillus has recently been found in the majority of women with bacterial 
vaginosis and in very few women without bacterial vaginosis. Its role in bacterial 
vaginosis is still not clear. The aim would be to find its prevalence in pregnant women 
and also its association with adverse pregnancy outcomes and infertility. 
 
Aerobic vaginitis has been recently defined. How much overlap is there between 
bacterial vaginosis and aerobic vaginitis and what is the role of aerobic vaginitis in 
adverse pregnancy outcomes? 
 
There is no data in Zimbabwe and the region on the association between BV and 
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Gram reagents, staining procedure and reading instructions for Nugent criteria 
Gram stain reagents 
• Methanol (fixative) 
• Crystal violet (primary stain) 
• Iodine solution (mordant) 
• Acetone (decolourizer) 
• Safranin (counter stain) 
Other supplies 
• Light microscope with 100X objective 
• Oil immersion 
• Timer 
• Filter paper  
• Staining rack 
• Fixing/staining trough with holder 
• Differential counting machines 
Procedure 
Fixing  
Arrange slides back to back on a slide holder and place in a trough containing 
methanol for 5 minutes. Remove slides and leave to dry freely in the air. If slides will 
not be stained immediately store them in a slide box labelled fixed. Include control 
slides during fixing, storage and staining. 
Staining  
1. Place between 5 and 10 slides on a staining rack and flood with crystal violet. 
Leave for 1 minute and wash with gentle running tape water. Shake excess 
water from the slide. (Do not stain more than 10 slides at a time.) 
2. Flood the slides with iodine solution and leave for 1 minute. Rinse again with 
gentle running tape water. Shake excess water from the slide. 
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3. Hold slide with forceps and add acetone drop wise until all the blue colour has 
completely run out. Quickly rinse slide in gentle running tape water. Repeat 
for all the slides on the rack. Care must be taken not to over decolourise. 
4. Flood slides with counter stain (safranin) and leave for 30 seconds. Rinse with 
gentle running tape water until all colour has run out. Shake off excess water. 
5. Blot dry by pressing gently face down on blotting paper. Turn the slide face up 
and allow to air dry before viewing it under the microscope. 
Reading slides according to Nugent’s criteria 
1. Scan the entire smear for adequacy of specimen. A smear must have several 
areas with cells and/or bacteria. An inadequate smear will have only mucus. 
Cells and bacteria will not be present. 
2. Using 40x objective scan the entire slide to get a better sense of the organisms 
present. Swing the 100x objective into place and read five random fields from 
various parts of the slide. Look for big gram- positive rods, small gram-
negative rods and curved gram-variable rods.  
3. Use differential counting device to count the total number of each organism in 
the five fields and divide by five to obtain an average. Use the average to 
obtain a score of the individual bacteria as shown in the table below. Each 
slide will yield three sets of scores, a score for long gram-positive rods 
(lactobacillus), a score for short gram-negative rods (G. vaginalis) and finally 
a score for curved gram variable rods (Mobiluncus).   
Add the individual scores to obtain the points for the slide. The points will 
determine the BV status of the client. Record result on appropriate record 
form. 
 
Scoring guide used for the enumeration of bacteria for the Nugent’s criteria. 
score  
grade 
Average number of 
bacteria per field Gram +ve Gram –ve Gram +/- 
4+ >30 0 4 
3+ 6-30 1 3 
 
2 
2+ 1-5 2 2 
1+ <1 3 1 
 
1 
0 0 4 0 0 
 
 48
Appendix 2   
Request to Participate. 
The bacterial vaginosis study is an ancillary to the Mother To Child Transmission 
(MTCT) study in which you are already enrolled. Bacterial vaginosis is a shift in the 
vaginal flora and is characterised by a milky white malodorous discharge, elevated pH 
and presence of clue cells. Usually the odour is more noticeable after sexual 
intercourse. Strictly speaking BV is not an STI. The most common symptoms of 
bacterial vaginosis are milky white adherent discharge and a fishlike odour although 
most women that have bacterial vaginosis do not show any of these symptoms. 
In pregnancy bacterial vaginosis is associated with amnionitis, chorioamnionitis, 
premature rupture of membranes, preterm births, low birth weight, intra-uterine deaths 
and stillbirths. It is also being increasingly associated with the acquisition of HIV-1 
and other sexually transmitted infections. 
There are many methods available for testing bacterial vaginosis but they are either 
too expensive or not suitable for the type of clinics we have in this country. In this 
study we want to see if we can come up with a simple method that can be used for the 
diagnosis of bacterial vaginosis in our clinics. 
The specimens that you submitted in the main MTCT study are enough for us to do 
this study, in particular the vaginal swabs obtained during gynaecologic examinations. 
No extra specimens will be taken from you. No direct benefits may accrue to you 
individually except for the services that you are already getting in the main study and 
the transport reimbursement.  
We are therefore asking for your permission to allow us to use your specimens for the 
bacterial vaginosis study. 
You give us this permission of your own free will and you are free to stop us from 
using your specimens at any time. This will not in any way jeopardize the services 
that you often get from the clinic or the main study. 




Study ID ……………………… 
 
The study information has been read to me and I understand the aim of the study. I 
show my willingness for my specimens to be used by putting my signature or a thumb 
print on this form. This I do of my own free will. 
 
 
___________________  _______  __________________ 
Signature of participant     Date   Interviewer’s signature 
 
 
I testify that I have, to the best of my ability read and explained the information 
concerning this research study to the participant whose study ID appears above.  
 
_______________________    _________________ 
Interviewer’s signature    Date 
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